The EuroFlow PID Orientation Tube for Flow Cytometric Diagnostic Screening of Primary Immunodeficiencies of the Lymphoid System

. 2019 ; 10 () : 246. [epub] 20190304

Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid30886612

In the rapidly evolving field of primary immunodeficiencies (PID), the EuroFlow consortium decided to develop a PID orientation and screening tube that facilitates fast, standardized, and validated immunophenotypic diagnosis of lymphoid PID, and allows full exchange of data between centers. Our aim was to develop a tool that would be universal for all lymphoid PIDs and offer high sensitivity to identify a lymphoid PID (without a need for specificity to diagnose particular PID) and to guide and prioritize further diagnostic modalities and clinical management. The tube composition has been defined in a stepwise manner through several cycles of design-testing-evaluation-redesign in a multicenter setting. Equally important appeared to be the standardized pre-analytical procedures (sample preparation and instrument setup), analytical procedures (immunostaining and data acquisition), the software analysis (a multidimensional view based on a reference database in Infinicyt software), and data interpretation. This standardized EuroFlow concept has been tested on 250 healthy controls and 99 PID patients with defined genetic defects. In addition, an application of new EuroFlow software tools with multidimensional pattern recognition was designed with inclusion of maturation pathways in multidimensional patterns (APS plots). The major advantage of the EuroFlow approach is that data can be fully exchanged between different laboratories in any country of the world, which is especially of interest for the PID field, with generally low numbers of cases per center.

Zobrazit více v PubMed

Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. . International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. (2018) 38:96–128. 10.1007/s10875-017-0464-9 PubMed DOI PMC

Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, et al. . The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. (2018) 38:129–43. 10.1007/s10875-017-0465-8 PubMed DOI PMC

Gallo V, Dotta L, Giardino G, Cirillo E, Lougaris V, D'Assante R, et al. . Diagnostics of primary immunodeficiencies through next-generation sequencing. Front Immunol. (2016) 7:466. 10.3389/fimmu.2016.00466 PubMed DOI PMC

Seleman M, Hoyos-Bachiloglu R, Geha RS, Chou J. Uses of next-generation sequencing technologies for the diagnosis of primary immunodeficiencies. Front Immunol. (2017) 8:847. 10.3389/fimmu.2017.00847 PubMed DOI PMC

Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who's who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. (2013) 43:2797–809. 10.1002/eji.201343751 PubMed DOI

Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira CE, van der Velden VH, Novakova M, et al. . Quality assessment program for EuroFlow protocols: summary results of four-year (2010-2013) quality assurance rounds. Cytometry A. (2015) 87:145–56. 10.1002/cyto.a.22581 PubMed DOI

Kalina T, Flores-Montero J, van der Velden VH, Martin-Ayuso M, Bottcher S, Ritgen M, et al. . EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. (2012) 26:1986–2010. 10.1038/leu.2012.122 PubMed DOI PMC

Blanco E, Perez-Andres M, Arriba-Mendez S, Contreras-Sanfeliciano T, Criado I, Pelak O, et al. . Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J Allergy Clin Immunol. (2018) 141:2208–19. 10.1016/j.jaci.2018.02.017 PubMed DOI

Perez-Andres M, Paiva B, Nieto WG, Caraux A, Schmitz A, Almeida J, et al. . Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin Cytom. (2010) 78 (Suppl. 1):S47–60. 10.1002/cyto.b.20547 PubMed DOI

Wickham H. Elegant Graphics for Data Analysis. New York, NY; Springer-Verlag; (2016).

Fuchs S, Rensing-Ehl A, Erlacher M, Vraetz T, Hartjes L, Janda A, et al. . Patients with T(+)/low NK(+) IL-2 receptor gamma chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency. Eur J Immunol. (2014) 44:3129–40. 10.1002/eji.201444689 PubMed DOI

Yao CM, Han XH, Zhang YD, Zhang H, Jin YY, Cao RM, et al. . Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011). J Clin Immunol. (2013) 33:526–39. 10.1007/s10875-012-9854-1 PubMed DOI

Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, et al. . A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. (2014) 133:1099–108. 10.1016/j.jaci.2013.10.007 PubMed DOI PMC

IJspeert H, Driessen GJ, Moorhouse MJ, Hartwig NG, Wolska-Kusnierz B, Kalwak K, et al. . Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes. J Allergy Clin Immunol. (2014) 133:1124–33. 10.1016/j.jaci.2013.11.028 PubMed DOI PMC

Notarangelo LD, Kim MS, Walter JE, Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol. (2016) 16:234–46. 10.1038/nri.2016.28 PubMed DOI PMC

van Zelm MC, Bartol SJ, Driessen GJ, Mascart F, Reisli I, Franco JL, et al. . Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol. (2014) 134:135–44. 10.1016/j.jaci.2013.11.015 PubMed DOI

van der Velden VH, Flores-Montero J, Perez-Andres M, Martin-Ayuso M, Crespo O, Blanco E, et al. . Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples. J Immunol Methods. (2017). [Epub ahead of print]. 10.1016/j.jim.2017.03.011. PubMed DOI

Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. . Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study. J Allergy Clin Immunol. (2017) 139:597–606 e4. 10.1016/j.jaci.2016.06.021 PubMed DOI PMC

Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol. (2012) 12:191–200. 10.1038/nri3158 PubMed DOI PMC

Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. . V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. (2001) 97:81–8. 10.1182/blood.V97.1.81 PubMed DOI

Muller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood. (2001) 98:1847–51. 10.1182/blood.V98.6.1847 PubMed DOI

Crestani E, Choo S, Frugoni F, Lee YN, Richards S, Smart J, et al. . RAG1 reversion mosaicism in a patient with Omenn syndrome. J Clin Immunol. (2014) 34:551–4. 10.1007/s10875-014-0051-2 PubMed DOI PMC

Stuchly J, Kanderova V, Vlkova M, Hermanova I, Slamova L, Pelak O, et al. Common variable immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia. Sci Rep. (2017) 7:39710 10.1038/srep39710 PubMed DOI PMC

Kalina T, Brdickova N, Glier H, Fernandez P, Bitter M, Flores-Montero J, et al. . Frequent issues and lessons learned from EuroFlow QA. J Immunol Methods. (2018). [Epub ahead of print]. 10.1016/j.jim.2018.09.008. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...